Readressing the rationale of irradiation in Stage I seminoma guidelines: A critical essay.

Berghen, Charlien; Albersen, Maarten; Blanchard, Pierre; Bossi, Alberto; Briganti, Alberto; Cozzarini, Cesare; Decaestecker, Karel; Fonteyne, Valérie; Haustermans, Karin; Joniau, Steven; Lim Joon, Daryl; Khoo, Vincent; Nguyen, Paul L; Ost, Piet; Villeirs, Geert; Vulsteke, Christof; Zietman, Anthony; De Meerleer, Gert

doi:10.1111/bju.14686

Title

Readressing the rationale of irradiation in Stage I seminoma guidelines: A critical essay.

Publication Date

2019

Author(s)

Berghen, Charlien

Albersen, Maarten

Blanchard, Pierre

Bossi, Alberto

Briganti, Alberto

Cozzarini, Cesare

Decaestecker, Karel

Fonteyne, Valérie

Haustermans, Karin

Joniau, Steven

Lim Joon, Daryl

Khoo, Vincent

Nguyen, Paul L

Ost, Piet

Villeirs, Geert

Vulsteke, Christof

Zietman, Anthony

De Meerleer, Gert

Type of document

Journal Article

OrcId

0000-0003-4785-3409

0000-0002-2203-4848

0000-0002-1947-9694

0000-0001-9661-1436

#PLACEHOLDER_PARENT_METADATA_VALUE#

DOI

10.1111/bju.14686

Abstract

Germ cell tumors (GCT), accounting for 95% of malignant testicular tumors, can be divided into two groups: seminoma (SGCT) and non-seminoma (NSGCT). Seminomas typically arise in men in the fourth decade of life, compromising 60% of the GCT. At diagnosis, approximately 75% present with local disease (Stage I); 15% is detected with metastatic regional lymph nodes (Stage II) and 5-10% present with juxtaregional or visceral metastasis (Stage III) . This article is protected by copyright. All rights reserved.

Link

link

Citation

BJU International 2019; 124(1): 35-39

Jornal Title

BJU International

Austin Health

Files: